153 related articles for article (PubMed ID: 1549362)
1. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
Hattori S; Maekawa M; Nakamura S
Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
[TBL] [Abstract][Full Text] [Related]
2. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
3. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
Basu TN; Gutmann DH; Fletcher JA; Glover TW; Collins FS; Downward J
Nature; 1992 Apr; 356(6371):713-5. PubMed ID: 1570015
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
Marshall MS; Hettich LA
Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
[TBL] [Abstract][Full Text] [Related]
5. Catalytic properties, tissue and intracellular distribution of neurofibromin.
Golubić M; Roudebush M; Dobrowolski S; Wolfman A; Stacey DW
Oncogene; 1992 Nov; 7(11):2151-9. PubMed ID: 1437143
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of rasGAP and neurofibromatosis gene product activities.
Bollag G; McCormick F
Nature; 1991 Jun; 351(6327):576-9. PubMed ID: 1904555
[TBL] [Abstract][Full Text] [Related]
7. Differences in the interaction of p21c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein.
DiBattiste D; Golubic M; Stacey D; Wolfman A
Oncogene; 1993 Mar; 8(3):637-43. PubMed ID: 8437847
[TBL] [Abstract][Full Text] [Related]
8. Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.
Böddrich A; Griesser J; Horn D; Kaufmann D; Krone W; Nürnberg P
Biochem Biophys Res Commun; 1995 Sep; 214(3):895-904. PubMed ID: 7575561
[TBL] [Abstract][Full Text] [Related]
9. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
Stang S; Bottorff D; Stone JC
Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
[TBL] [Abstract][Full Text] [Related]
10. Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP.
Boyer MJ; Gutmann DH; Collins FS; Bar-Sagi D
Oncogene; 1994 Feb; 9(2):349-57. PubMed ID: 8290249
[TBL] [Abstract][Full Text] [Related]
11. Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell.
Nakamura T; Nemoto T; Arai M; Yamazaki Y; Kasuga T; Gutmann DH; Collins FS; Ishikawa T
Am J Pathol; 1994 Mar; 144(3):549-55. PubMed ID: 8129040
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
Gutmann DH; Boguski M; Marchuk D; Wigler M; Collins FS; Ballester R
Oncogene; 1993 Mar; 8(3):761-9. PubMed ID: 8437860
[TBL] [Abstract][Full Text] [Related]
13. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
Abernathy CR; Colman SD; Kousseff BG; Wallace MR
Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387
[TBL] [Abstract][Full Text] [Related]
14. Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues.
Gutmann DH; Geist RT; Rose K; Wright DE
Dev Dyn; 1995 Mar; 202(3):302-11. PubMed ID: 7780179
[TBL] [Abstract][Full Text] [Related]
15. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
Guha A; Lau N; Huvar I; Gutmann D; Provias J; Pawson T; Boss G
Oncogene; 1996 Feb; 12(3):507-13. PubMed ID: 8637706
[TBL] [Abstract][Full Text] [Related]
16. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetics of neurofibromatosis type 1].
Suzuki H; Takahashi K; Shibahara S
Nihon Rinsho; 1993 Sep; 51(9):2457-61. PubMed ID: 8411728
[TBL] [Abstract][Full Text] [Related]
18. Antibody against neurofibromatosis type 1 gene product reacts with a triton-insoluble GTPase activating protein toward ras p21.
Hattori S; Ohmi N; Maekawa M; Hoshino M; Kawakita M; Nakamura S
Biochem Biophys Res Commun; 1991 May; 177(1):83-9. PubMed ID: 1904223
[TBL] [Abstract][Full Text] [Related]
19. Coupling of ras p21 signalling and GTP hydrolysis by GTPase activating proteins.
McCormick F
Philos Trans R Soc Lond B Biol Sci; 1992 Apr; 336(1276):43-7; discussion 47-8. PubMed ID: 1351295
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 1 gene mutations in neuroblastoma.
The I; Murthy AE; Hannigan GE; Jacoby LB; Menon AG; Gusella JF; Bernards A
Nat Genet; 1993 Jan; 3(1):62-6. PubMed ID: 8490657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
